Chateal EQ NDC 50102-230

NDC codes

FDA NDC Directory

Product NDC (as listed)50102-230Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50102-0230Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50102-230-23	50102023023	3 POUCH in 1 CARTON (50102-230-23) / 1 BLISTER PACK in 1 POUCH (50102-230-21) / 1 KIT in 1 BLISTER PACKMarketed from Sep 23, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chateal EQ
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Afaxys Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206866
Marketing start: Sep 23, 2016
Listing expires: Dec 31, 2026
Identifiers: Product ID 50102-230_e3747d40-54e9-42c7-a1b9-3e112ea995b4SPL ID e3747d40-54e9-42c7-a1b9-3e112ea995b4SPL set ID 4c59652c-49a6-4eed-b557-9abd3ffac541RxCUI 238019, 748797, 748878, 1364848

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450102023023 followed by a unit qualifier and the quantity

Package 50102-0230-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Chateal EQ is indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206866

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206866
Product	Strength	Form · route	Labeler	Product NDC
Ayunalevonorgestrel and ethinyl estradiol	—	Kit	Aurobindo Pharma Limited	65862-848